Abstract
Increased febrile reactions in Australian children from one influenza vaccine brand in 2010 diminished confidence in influenza immunisation, highlighting the need for improved vaccine safety surveillance. AusVaxSafety, a national vaccine safety surveillance system collected adverse events in young children for 2015 influenza vaccine brands in real time through parent/carer reports via SMS/email. Weekly cumulative data on 3,340 children demonstrated low rates of fever (4.4%) and medical attendance (1.1%). Fever was more frequent with concomitant vaccination.
Original language | English |
---|---|
Pages (from-to) | 6-10 |
Journal | Eurosurveillance (Print) |
Volume | 20 |
Issue number | 43 |
DOIs | |
Publication status | Published - 2015 |